Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport

Raghavendra Gowda, Gajanan S. Inamdar, Omer Kuzu, Saketh S. Dinavahi, Jacek Krzeminski, Madhu Babu Battu, Sreedhara R. Voleti, Shantu Amin, Gavin P. Robertson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Leelamine is an anticancer chemotherapeutic agent inhibiting intracellular cholesterol transport. Cell death mediated by leelamine occurs due to the lysosomotropic property of the compound, its accumulation in the lysosome, and inhibition of cholesterol transport leading to lack of availability for key processes required for functioning of cancer cells. The present study dissects the structure-activity-relationship of leelamine using synthesized derivatives of leelamine and abietic acid, a structurally similar compound, to identify the moiety responsible for anti-cancer activity. Similar to leelamine, all active derivatives had an amino group or a similar moiety that confers a lysosomotropic property to the compound enabling its accumulation in the lysosome. Active derivatives inhibited intracellular cholesterol transport and hindered xenografted melanoma tumor development without obvious systemic toxicity. In silico studies suggested that active derivatives accumulating in lysosomes bound to NPC1, a protein responsible for cholesterol export from the lysosome, to inhibit its activity that then caused accumulation, and lack of cholesterol availability for other key cellular activities. Thus, active derivatives of leelamine or abietic acid maintained lysosomotropic properties, bound to NPC1, and disrupted cellular cholesterol transport as well as availability to retard tumor development.

Original languageEnglish
Pages (from-to)28260-28277
Number of pages18
JournalOncotarget
Volume8
Issue number17
DOIs
Publication statusPublished - 1 Jan 2017
Externally publishedYes

    Fingerprint

Keywords

  • Abietic acid
  • AKT
  • Leelamine
  • Melanoma
  • Structure-activity relationship

ASJC Scopus subject areas

  • Oncology

Cite this

Gowda, R., Inamdar, G. S., Kuzu, O., Dinavahi, S. S., Krzeminski, J., Battu, M. B., Voleti, S. R., Amin, S., & Robertson, G. P. (2017). Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport. Oncotarget, 8(17), 28260-28277. https://doi.org/10.18632/oncotarget.16002